People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Pharma, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fuse Oncology, Inc. | — | Pharma | Series A | $11.8M | $79.4M | 2021 |
| SiteLabs Inc. | — | Other Health Care | Seed | $2.0M | $5.5M | 2025 |
James Bauler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Bauler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Miller | 1 | 27 |
| Jay Brennan | 1 | 2 |
| Eric Beier | 1 | 2 |
| Darren Schaupp | 1 | 1 |
| Warren Dodge | 1 | 1 |
| Stephen Fischbach | 1 | 1 |
| Benjamin Sintay | 1 | 1 |
| John Strider | 1 | 1 |
| David Wiant | 1 | 1 |
| David Wiantt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.